Temporary mechanical circulatory support (MCS) is employed to stabilize patients with
refractory heart failure as a bridge to decision, recovery, durable ventricular assist device …

Abstract Background Impella RP (Abiomed, Danvers, MA, USA) is indicated for right
ventricular failure after left ventricular assist device insertion or biventricular shock. Once the …

Aims Pre‐operative or post‐operative heart failure (HF) and cardiogenic shock of various
natures frequently remain refractory to conservative treatment and require mechanical …

Cardiogenic shock remains a significant cause of mortality and morbidity in children with
heart failure. Percutaneous mechanical circulatory support may be an additional tool to …

Temporary mechanical circulatory support devices for the treatment of acute right ventricular
failure represent crucial tools for clinical practice. Right ventricular failure presents specific …

The Impella 5.5 left ventricular assist device (LVAD) is typically placed in a hybrid operating
room with fluoroscopic and echocardiographic guidance under general anesthesia. In this …

Background: The Impella 2.5 and Impella Cardiac Power (CP) devices (ABIOMED) are used
to provide mechanical circulatory support for high-risk percutaneous coronary interventions …

Abstract Background The Impella (Abiomed) ventricular support system is a family of
temporary mechanical circulatory support (MCS) devices used to treat patients with …

Abstract Impella (Abiomed, Danvers, MA, USA) is a recently-innovated (commercially
available from 2017 in Japan) percutaneous left ventricular assist device which is inserted …

Background Biventricular failure is associated with high in‐hospital mortality. Limited data
regarding the efficacy of biventricular Impella axial flow catheters (BiPella) support for …